BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38214605)

  • 41. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.
    Nakhaei P; Mesplede T; Solis M; Sun Q; Zhao T; Yang L; Chuang TH; Ware CF; Lin R; Hiscott J
    PLoS Pathog; 2009 Nov; 5(11):e1000650. PubMed ID: 19893624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
    Vazquez C; Tan CY; Horner SM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SIAH1 modulates antiviral immune responses by targeting deubiquitinase USP19.
    Weerawardhana A; Herath TUB; Gayan Chathuranga WA; Kim TH; Ekanayaka P; Chathuranga K; Kang HC; Jung JU; Lee JS
    J Med Virol; 2024 Mar; 96(3):e29523. PubMed ID: 38483060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.
    You F; Sun H; Zhou X; Sun W; Liang S; Zhai Z; Jiang Z
    Nat Immunol; 2009 Dec; 10(12):1300-8. PubMed ID: 19881509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.
    He TS; Huang J; Chen T; Zhang Z; Cai K; Yu J; Xu LG
    Microbiol Spectr; 2021 Dec; 9(3):e0145821. PubMed ID: 34908452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
    Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
    mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zebrafish MARCH8 downregulates fish IFN response by targeting MITA and TBK1 for protein degradation.
    Zhao X; Dan C; Gong XY; Li YL; Qu ZL; Sun HY; An LL; Guo WH; Gui JF; Zhang YB
    Dev Comp Immunol; 2022 Oct; 135():104485. PubMed ID: 35764162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BST2 inhibits type I IFN (interferon) signaling by accelerating MAVS degradation through CALCOCO2-directed autophagy.
    Jin S; Cui J
    Autophagy; 2018; 14(1):171-172. PubMed ID: 29165031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes.
    Liu X; Xu F; Ren L; Zhao F; Huang Y; Wei L; Wang Y; Wang C; Fan Z; Mei S; Song J; Zhao Z; Cen S; Liang C; Wang J; Guo F
    Nat Commun; 2021 Jul; 12(1):4427. PubMed ID: 34285233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel protein encoded by circVPS13D attenuates antiviral innate immunity by targeting MAVS in teleost fish.
    Wang L; Song Y; Yan X; Xu T
    J Virol; 2023 Nov; 97(11):e0088623. PubMed ID: 37843373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAVS-loaded unanchored Lys63-linked polyubiquitin chains activate the RIG-I-MAVS signaling cascade.
    Liu F; Zhuang W; Song B; Yang Y; Liu J; Zheng Y; Liu B; Zheng J; Zhao W; Gao C
    Cell Mol Immunol; 2023 Oct; 20(10):1186-1202. PubMed ID: 37582970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HFE inhibits type I IFNs signaling by targeting the SQSTM1-mediated MAVS autophagic degradation.
    Liu J; Wu X; Wang H; Wei J; Wu Q; Wang X; Yan Y; Cui J; Min J; Wang F; Zhou J
    Autophagy; 2021 Aug; 17(8):1962-1977. PubMed ID: 32746697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors.
    Castanier C; Zemirli N; Portier A; Garcin D; Bidère N; Vazquez A; Arnoult D
    BMC Biol; 2012 May; 10():44. PubMed ID: 22626058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
    Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH
    J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative Regulatory Role of the Spring Viremia of Carp Virus Matrix Protein in the Host Interferon Response by Targeting the MAVS/TRAF3 Signaling Axis.
    Wang YY; Chen YL; Ji JF; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Virol; 2022 Aug; 96(16):e0079122. PubMed ID: 35913215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EGR1 Suppresses Porcine Epidemic Diarrhea Virus Replication by Regulating IRAV To Degrade Viral Nucleocapsid Protein.
    Wang H; Kong N; Jiao Y; Dong S; Sun D; Chen X; Zheng H; Tong W; Yu H; Yu L; Zhang W; Tong G; Shan T
    J Virol; 2021 Sep; 95(19):e0064521. PubMed ID: 34287043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Porcine RING Finger Protein 114 Inhibits Classical Swine Fever Virus Replication via K27-Linked Polyubiquitination of Viral NS4B.
    Zhang Y; Zhang H; Zheng GL; Yang Q; Yu S; Wang J; Li S; Li LF; Qiu HJ
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA.
    Li W; Li N; Dai S; Hou G; Guo K; Chen X; Yi C; Liu W; Deng F; Wu Y; Cao X
    FASEB J; 2019 Sep; 33(9):9929-9944. PubMed ID: 31180720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity via Interfering with MAVS Aggregation.
    Zhang H; Li X; Wang Y; Liu X; Guo J; Wang Z; Zhang L; Xiong S; Dong C
    J Immunol; 2023 Nov; 211(9):1406-1417. PubMed ID: 37695673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.